Name : BBS7 Antibody, ALEXA FLUOR 350
Supplier : BIOSS PRIMARY CONJUGATED ANTIBODIES
Price :332
SKU : GEN3009437735
| Long name | ALEXA FLUOR 350 Conjugated, BBS7 Polyclonal Antibody |
| Also known as | Anti-BBS7 PAb ALEXA FLUOR 350 |
| Category | Conjugated Primary Antibodies |
| Conjugated with | 350, ALEXA FLUOR® |
| Host Organism | Rabbit (Oryctolagus cuniculus) |
| Target Antigen | BBS7 |
| Specificity | This is a highly specific antibody against BBS7 |
| Modification | Unmodified |
| Modification Site | None |
| Clonality | Polyclonal |
| Clone | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BBS7 |
| Tested applications | IF(IHC-P) |
| Recommended dilutions | IF(IHC-P)(1:50-200) |
| Crossreactivity | Mouse, Rat, Human |
| Cross-reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the antigen | BBS is a heterogeneous disorder mapping to eight genetic loci and encoding eight proteins, BBS patients also have an increased risk of developing diabetes, BBS1-BBS8, BBS2 contains two overlapping genes: BBS2L1 and BBS2L2, BBS7 contains 672 amino acids and is expressed at low to moderate levels in most human tissues, BBSL1 was re-named BBS7, Five BBS proteins encode basal body or cilia proteins, and congenital heart defects, and developmental delay, hypertension, hypogenitalism, photoreceptor degeneration, polydactyly, renal abnormalities, suggesting that BBS is a ciliary dysfunction disorder, whereas BBS2L2 independently funcitons as BBS1, Bardet-Biedl syndrome (BBS) is a pleiotropic genetic disorder characterized by obesity |
| Purification | Purified by Protein A |
| Storage conditions | 50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA |
| Excitation emission | 343nm/442nm |
| Synonyms | FLJ10715 BBS2L1 |
| Properties | ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 350 conjugates can be used in multi-color flow cytometry with FACS's equipped with a second red laser or red diode, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate |
| Conjugation | ALEXA FLUOR 350, Alexa Fluor |
| Gene target | BBS7 |
| Short name | BBS7 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Label | ALEXA FLUOR 350 |
| Alternative name | ALEXA FLUOR 350, Bardet-Biedl syndrome 7 (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | BBS7 and IDBG-36452 and ENSG00000138686 and 55212, BBS7 and IDBG-639728 and ENSBTAG00000004945 and 100138953, Bbs7 and IDBG-138825 and ENSMUSG00000037325 and 71492, nuclei, protein binding, this GO :0001103 and RNA polymerase II repressing transcription factor binding and molecular function this GO :0001654 and eye development and biological process this GO :0001947 and heart looping and biological process this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0005930 and axoneme and cellular component this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0007224 and smoothened signaling pathway and biological process this GO :0007368 and determination of left/right symmetry and biological process this GO :0007420 and brain development and biological process this GO :0007507 and heart development and biological process this GO :0007601 and visual perception and biological process this GO :0008104 and protein localization and biological process this GO :0015031 and protein transport and biological process this GO :0032402 and melanosome transport and biological process this GO :0032436 and positive regulation of proteasomal ubiquitin-dependent protein catabolic process and biological process this GO :0034464 and BBSome and cellular component this GO :0035058 and nonmotile primary cilium assembly and biological process this GO :0036064 and ciliary basal body and cellular component this GO :0045444 and fat cell differentiation and biological process this GO :0048546 and digestive tract morphogenesis and biological process this GO :0051877 and pigment granule aggregation in cell center and biological process this GO :0060021 and palate development and biological process this GO :0060170 and ciliary membrane and cellular component this GO :0060173 and limb development and biological process this GO :0060271 and cilium morphogenesis and biological process, this GO :0001103: RNA polymerase II repressing transcription factor binding, this GO :0001103: RNA polymerase II repressing transcription factor binding and also this GO :0005515: protein binding, this GO :0005515: protein binding, Bardet-Biedl syndrome 7 |
| Identity | 18758 |
| Gene | BBS7 |
| Long gene name | Bardet-Biedl syndrome 7 |
| Locus | 4q27 |
| Discovery year | 2003-02-05 |
| GenBank acession | AF521644 |
| Entrez gene record | 55212 |
| Classification | Bardet-Biedl syndrome associated BBSome |
| Havana BLAST/BLAT | OTTHUMG00000133076 |
| Locus Specific Databases | Mutations of the Bardet-Biedl Syndrome Type 7 Gene (BBS2L1) |